Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 1;39(4):315-322.
doi: 10.1097/HCO.0000000000001151. Epub 2024 Apr 24.

Myocarditis in children 2024, new themes and continued questions

Jason F Goldberg  1 , Joseph A Spinner  2 , Jonathan H Soslow  3
Affiliations
Review

Myocarditis in children 2024, new themes and continued questions

Jason F Goldberg et al. Curr Opin Cardiol. .

Abstract

Purpose of review: While pediatric myocarditis incidence has increased since the coronavirus disease 2019 (COVID-19) pandemic, there remain questions regarding diagnosis, risk stratification, and optimal therapy. This review highlights recent publications and continued unanswered questions related to myocarditis in children.

Recent findings: Emergence from the COVID-19 era has allowed more accurate description of the incidence and prognosis of myocarditis adjacent to COVID-19 infection and vaccine administration as well that of multi-system inflammatory disease in children (MIS-C). As cardiac magnetic resonance technology has shown increased availability and evidence in pediatric myocarditis, it is important to understand conclusions from adult imaging studies and define the use of this imaging biomarker in children. Precision medicine has begun to allow real-time molecular evaluations to help diagnose and risk-stratify cardiovascular diseases, with emerging evidence of these modalities in myocarditis.

Summary: Recent information regarding COVID-19 associated myocarditis, cardiac magnetic resonance, and molecular biomarkers may help clinicians caring for children with myocarditis and identify needs for future investigations.

PubMed Disclaimer

References

    1. Kim J, Cho MJ. Acute myocarditis in children: a 10-year nationwide study (2007–2016) based on the health insurance review and assessment service database in Korea. Korean Circ J 2019; 50:1013–1022.
    1. Arola A, Pikkarainen E, Sipilä JO, et al. Occurrence and features of childhood myocarditis: a nationwide study in Finland. J Am Hear Assoc 2017; 6:e005306.
    1. Canter CE, Simpson KP. Diagnosis and treatment of myocarditis in children in the current era. Circulation 2014; 129:115–128.
    1. Fairweather D, Beetler DJ, Florio DND, et al. COVID-19, myocarditis and pericarditis. Circ Res 2023; 132:1302–1319.
    1. Law YM, Lal AK, Chen S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation 2021; 144:e123–e135.

Supplementary concepts